Medtronic’s hybrid closed loop automated insulin system, which combines an automated insulin pump with a continuous glucose monitor, gained CE Mark approval.

The device uses a new sensor to achieve a fully closed loop system and it has a built-in algorithm to prevent glucose spikes and allow for better diabetes management.

The new sensor, which is 80 percent smaller than its predecessor, uses a battery that has been improved to last seven days instead of six.